We have investigated the capacity of our established thymic stromal cell clone (MRL104.8a) or its derived factor(s) to induce the differentiation of immature thymocytes. Culture of purified adult murine double-negative (CD4-CD8-, indicated here as CD4-8-) thymocytes on the MRL104.8a thymic stromal cell monolayer for 1 day resulted in the induction of an appreciable percentage of CD4-8+ thymocytes. A bone marrow-derived stromal cell monolayer or a L929 fibroblast monolayer failed to generate CD4-8+ cells. This differentiation could also be induced by a semipurified sample of the MRL14.8a culture supernatant, which contained a thymic stroma-derived T-cell growth factor capable of contributing to the growth of double-negative immature thymocytes. CD4-8+ thymocytes generated 1 day after coculture with the MRL104.8a cells or the sample containing thymic stroma-derived T-cell growth factor were found to be CD3-and J11d+, excluding the possibility of expansion of mature (CD3+4-8+) thymocytes present in the thymus. More importantly, when the culture period was extended to 2 or 3 days, an appreciable number of CD4+8+ and single-positive (CD4+) cells were generated on the MRL104.8a monolayer. Thus, these results provide the direct demonstration that CD3-4-8-immature thymocytes are promoted to differentiate through a rapidly cycling intermediate (CD3-4-8+) into double-and single-positive cells by a specialized thynic stromal component.
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Within the thymus, T-cell precursors derived from bone marrow undergo extensive proliferation and differentiation to acquire the phenotypic markers and functional reactivities characteristic of mature T cells (1) (2) (3) . Intrathymic T-lineage cells are divided into four major subpopulations based on the expression of CD4 and CD8 antigens (2) . Double-negative (CD4-CD8-, indicated here as CD4-8-) thymocytes represent immature cells with the capacity to give rise to the other two single-positive (CD4-8+ and CD4+8-) mature subsets through the stage of CD4+8+ cells (4) (5) (6) (7) . Recent studies have also revealed the existence of a rapidly cycling intermediate (CD3-4-8+) in the generation of CD4+8+ cells (2, (8) (9) (10) (11) (12) . While these studies helped us to understand the sequence of events occurring during intrathymic T-cell maturation, cellular and molecular mechanisms involved in such maturation remain to be investigated. Since the microenvironment provided by thymic stromal components has a critical role in T-cell maturation as well as repertoire selection in the thymus (1) (2) (3) This laboratory has recently established a thymic stromal cell clone, MRL104.8a (13) , that produces a T-cell growth factor designated thymic stroma-derived T-cell growth factor (TSTGF) (14, 15) . We demonstrated that this factor is capable of contributing to the proliferation of CD3-4-8-immature thymocytes (16 
MATERIALS AND METHODS
Thymic Stroma-Derived Cell Clone. The thymic stromaderived cell clone utilized (MRL104.8a) was established in our laboratory from long-term liquid-phase cultures ofthymic stromal cells from MRL Ipr/lpr mice (13) . As stromal cell controls, a bone marrow stromal cell clone (BSL-35.6) that has been recently established from MRL lpr/lpr mouse bone marrow (H. Matsubara and H.F., unpublished data) and a L929 fibroblast cell line were used.
Reagents and Monoclonal Antibodies. Recombinant human interleukin la (IL-la), murine IL-2, and murine IL-7 were kindly provided by Dainippon Seiyaku (Osaka), Shionogi Pharmaceutical (Osaka), and DNAX, respectively. The following monoclonal antibodies were used: anti-Lyt-2 (3.155) (obtained from the American Type Culture Collection), anti-L3T4 [GK1. 5 (17) and RL172.4 (18) ], anti-T3 (2C11) (19) , anti-Jlld (20) , and anti-IL-2 receptor (IL-2R) antibody (7D4) (21) . For cell staining, fluorescein isothiocyanate (FITC)-conjugated anti-L3T4 antibody was prepared as described (22 ,uM 2-mercaptoethanol, and gentamycin (50 pug/ml) was used throughout this study, including the maintenance ofthe MRL104.8a thymic stromal cell clone.
Preparation of Double-Negative Thymocyte Population. C3H/He young adult (3-to 5-week-old) thymocytes were suspended in Hanks' balanced salt solution containing 2% (vol/vol) fetal bovine serum. Antibodies to CD8 (3.155) and CD4 (RL172.4) were added to give predetermined optimum concentrations, and cells were left on ice for 30 min. Cells were pelleted by centrifugation and resuspended at 5 x 107 cells per ml in rabbit complement (Low Tox-M rabbit complement; Cederlane, Ontario, Canada). Three complementmediated killing cycles were performed in sequence. Only the double-negative cell preparations that were >98% pure were used in this study. In some experiments, double-negative cells were obtained by sorting cells after two complementmediated killing cycles by using the FACS IV instrument (Becton Dickinson) according to the procedure described (12) . This series of procedures gave >99% purity.
Immunofluorescence Staining and Flow Microfluorometry.
Cells were stained with FITC-conjugated anti-L3T4 (GK1. 5) antibody and with biotinylated anti-Lyt-2 antibody followed by PE-conjugated streptavidin (CD4 vs. CD8). Alternatively, cells were doubly stained by (i) anti-T3 (2C11) antibody followed by FITC-conjugated goat anti-hamster immunoglobulin and (ii) biotin-conjugated anti-Lyt-2 followed by PE-avidin. Before ii, cells were treated with rat immunoglobulin at 1 mg/ml to block cross-reactive antibody sites. Thus i and ii detect CD3 and CD8, respectively. Cells were also stained with FITC-conjugated anti-Thy-1.2 antibody and then with anti-Lyt-2-biotin, followed by PE-avidin (Thy-1.2 vs. CD8). In the case of staining for CD8 vs. Jlld and CD8
vs. IL-2R, the procedure was similar to that performed for CD8 vs. CD3, except that FITC-conjugated goat anti-rat immunoglobulin-was used in place of goat anti-hamster immunoglobulin. CD4 was also stained by PE-conjugated anti-L3T4 antibody in combination with staining for CD3 (CD4 vs. CD3). Cells were analyzed for two-color fluorescence with a FACStar (Becton Dickinson) with logarithmic intensity scales. In most cases 104 cells were scored, ofwhich 60-80%o were included in the analysis.
RESULTS
Generation of a CD3-4-8+ Intermediate Thymocyte Population After a 1-Day Culture Period on a MORL104.8a Mono- layer. Double-negative thymocytes were isolated from normal C3H/He thymuses after three killing cycles using anti-L3T4 and anti-Lyt-2 antibodies in the presence of complement. More than 98% of the resulting cells were of the double-negative phenotype. This was also confirmed by staining treated cells with FITC-conjugated goat anti-rat immunoglobulin. These cells were cultured alone or on a monolayer of MRL104.8a thymic stromal cells, BSL-35. 6 bone marrow stromal cells, or L929 fibroblasts. The recovery of viable cells was in the range of 4-13% of input, and only a marginal number of cells expressed CD4 and/or CD8 antigens when the cells were cultured alone (Fig. la) . In contrast, a greater percentage of cells (20-35% of input in six experiments) was recovered after culturing for 1 day on the MRL104.8a monolayer, and an appreciable percentage of these cells expressed CD8 but not CD4 antigens (Fig. lb) .
The induction of CD8 antigens required the MRL104.8a thymic stromal monolayer since the CD8 antigen was not induced on double-negative cells by a bone marrow stromal cell monolayer or an L929 fibroblast monolayer ( Fig. 1 However, almost all of these cells were "maturing" thymocytes, since they were Thy-1`0 and IL-2R-, as exemplified by CD8+ populations (Fig. 4 e and f) .
It is known that MRL104.8a cells produce TSTGF, but neither IL-1 nor IL-2 activity is detected in its culture supernatant (13 (Fig. 5) .
The differentiation of double-negative cells was further promoted when the culture period was extended to 3 days ( Fig. 6) . The number ofCD4-8' cells induced decreased from day 1 to day 3; in contrast, there was an increase in the percentage of CD4+8' cells on day 3 relative to the percentage on day 1. Moreover, an appreciable number of CD4+8-cells emerged on day 3, and a small number of CD4-8' cells still remained at this stage. The differentiation observed on days 2 and 3 was again dependent on the MRL104.8a monolayer; when double-negative cells were cultured for 1 day on bone marrow stromal cells in the presence of the semipurified TSTGF sample, a sufficient number of viable cells were recovered, and comparable percentages (10- 
DISCUSSION
The process of T-cell development within the thymus is marked by the activation and/or inactivation of a set ofgenes encoding components of TCRs for antigen as well as other sets of genes whose expression may represent a stage of T-cell differentiation (27) . Knowledge has increasingly accumulated to help us understand the elusive lineage pathway between CD4-8-thymocytes and their mature progeny (2, 4, 5, (8) (9) (10) (11) (12) . However, more precise determination of lineage relationships between various immature and mature thymo- cyte subsets as well as cellular and molecular mechanisms underlying such an intrathymic maturational process remain to be investigated, especially based on the interaction of maturing thymocytes with thymic stromal components capable of providing the thymic microenvironment. The major findings to emerge from the present study are that (i) the monolayer of our established thymic stromal cell clone is capable of promoting the differentiation of immature double-negative thymocytes through a CD3-4-8' intermediate into more mature stages and (ii) the initiation of such differentiation was also inducible by the monolayer-derived soluble factor(s) without requiring direct interaction with stromal cells. In contrast to earlier reports that a proportion of CD4-8-cells differentiate into CD4+8' cells following overnight culture in the absence of added mitogens or growth factors (28) , the differentiation of CD4-8-was induced only when double-negative thymocytes were placed on the MRL104.8a thymic stromal cell monolayer. A possibility that this is due to a mere feeder (monolayer) effect was excluded by the fact that the differentiation was not inducible by bone marrow-derived stromal cell or by L929 fibroblast cell monolayers. Thus, this study not only supports the thus far proposed sequence of intrathymic T-cell maturation but also demonstrates the distinct properties of our established thymic stromal cell clone.
The present results should also be discussed in several aspects. First, although the differentiation ofdouble-negative cells into CD3-4-8' cells was reproducibly observed in the presence of the MRL104.8a thymic stromal monolayer or its derived factor(s), some but not all ofthe double-negative cells were promoted into differentiation. The Our results illustrate differentiation of immature thymocytes from young adult mice that is dependent on the specialized thymic stromal monolayer. It has been well accepted that T-cell maturation and thymic selection (positive and negative) require the interaction of maturing thymocytes and thymic stromal components (1) (2) (3) . In addition to the capacities to promote the growth and differentiation of immature thymocytes, it was shown that the MRL104.8a stromal clone can induce clonal deletion of T cells that is dependent on the stimulation of TCRs with antigen and/or H-2 molecules expressed on its monolayer (29) . When combined with the utilization of antibodies against various molecules expressed on thymic stromal cells and defined specificity groups of TCRs, our stromal cells could provide an in vitro model for investigating more precisely the maturation and selection events occurring in the thymus.
